DE602006010934D1 - Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika - Google Patents

Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika

Info

Publication number
DE602006010934D1
DE602006010934D1 DE602006010934T DE602006010934T DE602006010934D1 DE 602006010934 D1 DE602006010934 D1 DE 602006010934D1 DE 602006010934 T DE602006010934 T DE 602006010934T DE 602006010934 T DE602006010934 T DE 602006010934T DE 602006010934 D1 DE602006010934 D1 DE 602006010934D1
Authority
DE
Germany
Prior art keywords
apr
peptides
immunogenicity
immunogenic
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010934T
Other languages
English (en)
Inventor
Harald Kropshofer
Anne Vogt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602006010934D1 publication Critical patent/DE602006010934D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE602006010934T 2005-04-20 2006-04-10 Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika Active DE602006010934D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05103199 2005-04-20

Publications (1)

Publication Number Publication Date
DE602006010934D1 true DE602006010934D1 (de) 2010-01-21

Family

ID=37114190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010934T Active DE602006010934D1 (de) 2005-04-20 2006-04-10 Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika

Country Status (8)

Country Link
US (1) US20060251664A1 (de)
JP (1) JP4275144B2 (de)
CN (1) CN1877336A (de)
AT (1) ATE451618T1 (de)
CA (1) CA2542104C (de)
DE (1) DE602006010934D1 (de)
ES (1) ES2334936T3 (de)
SG (1) SG126893A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5331714B2 (ja) * 2007-03-16 2013-10-30 コヴァルクス・アーゲー タンパク質複合体をターゲティングする薬物候補の直接質量分析
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
WO2013119947A1 (en) 2012-02-09 2013-08-15 Baylor College Of Medicine Pepmixes to generate multiviral ctls with broad specificity
TWI719939B (zh) * 2014-07-14 2021-03-01 日商中外製藥股份有限公司 鑑定蛋白質抗原決定位之方法
WO2017049291A1 (en) 2015-09-18 2017-03-23 Baylor College Of Medicine Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
WO2018189148A1 (en) 2017-04-10 2018-10-18 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
CA3059644A1 (en) 2017-04-10 2018-10-18 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
AU2019269641A1 (en) * 2018-05-17 2020-12-03 Immunome, Inc. CH3 domain epitope tags

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60320196T2 (de) * 2002-10-02 2009-05-14 F. Hoffmann-La Roche Ag Verfahren zur Identifizierung antigener Peptide

Also Published As

Publication number Publication date
ATE451618T1 (de) 2009-12-15
CN1877336A (zh) 2006-12-13
JP2006300945A (ja) 2006-11-02
JP4275144B2 (ja) 2009-06-10
SG126893A1 (en) 2006-11-29
US20060251664A1 (en) 2006-11-09
CA2542104A1 (en) 2006-10-20
CA2542104C (en) 2010-12-07
ES2334936T3 (es) 2010-03-17

Similar Documents

Publication Publication Date Title
DE602006010934D1 (de) Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika
CY1120822T1 (el) Διαειδικα ειδικη επικρατεια δεσμευσης
WO2004063963A3 (en) Novel proteins with altered immunogenicity
RS52782B (en) HIGH AFINITY HUMAN ANTIBODIES FOR THE HUMAN IL-4 RECEPTOR
EP2534257A4 (de) Verfahren zur identifikation und isolierung von zellen zur expression von polypeptiden
NZ591704A (en) Peptide vaccines for cancers expressing tumor-associated antigens
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
WO2007064919A3 (en) Binding polypeptides with restricted diversity sequences
ATE521708T1 (de) Chimärische, hybrid- und tandem-polypeptide von meningococcus nmb1870
MY148646A (en) Anti-psgl-1 antibodies
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
MX2014005546A (es) Anticuerpos de union de albumina y fragmentos de union de los mismos.
DE60139542D1 (de) Methoden zur herstellung humaner monoklonaler antikörper
AR072897A1 (es) Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5
AR083747A1 (es) Anticuerpos anti-il-23
TW200515916A (en) Chimeric antigens for breaking host tolerance to foreign antigens
WO2009051555A3 (en) Modified mhc class i binding peptides
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
WO2011022077A3 (en) A nucleic acid cassette for producing recombinant antibodies
WO2007146401A3 (en) Denatured collagen peptides and uses thereof
WO2005012531A3 (en) Antibody cdr polypeptide sequences with restricted diversity
EP4269562A3 (de) Antigenbindende moleküle und verfahren zur verwendung davon
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2014144911A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage
UA101142C2 (ru) Способ разработки антитела

Legal Events

Date Code Title Description
8364 No opposition during term of opposition